TrialBlood cancer journal2023

Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study.

Fen Saj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.